NCT04782180CompletedPhase 4
PrEP at a Syringe Services Program
Mobile Delivery of PrEP at a Syringe Services Program-A Pilot Study
Source: ClinicalTrials.gov · Last updated 19 Dec 2025
Brief summary (registry, in English)
The purpose of this study is to see if providing participants with pre-exposure prophylaxis (PrEP) medicine right away at the IDEA Exchange will help participants remain in HIV negative.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (actual)
- First submitted
- 1 Mar 2021
- Start date
- 1 Feb 2022
- Primary completion date
- 11 Nov 2024
- Lead sponsor
- University of Miami
- Diseases
- HIV
- NCT number
- NCT04782180
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 90
- From 1 Feb 2022 to the primary completion date, 11 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- test positive for HIV via rapid test
- have symptoms acute HIV.
Other
- do not meet the above criteria of inclusion
- decline to participate
- are pregnant or plan on becoming pregnant
- Any other comorbidities that at the discretion of the investigator would prevent the participant from participating in the study.
Who the study is looking for
- over the age of 18
- speak either English or Spanish
- ability to provide informed consent
- currently enrolled in the syringe services program
- have a negative HIV rapid test result
- estimated creatinine clearance \> 30 ml/minute
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Miami Coordinator of this site? Confirm its status | Miami | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.